Rancho Santa Fe, CA, United States of America

John C Reed

This inventor holds 85 USPTO granted patents and 13 published patent applications and 2 EPO patents, primarily in Apoptosis Modulation (CPC class 435-6). Top assignees: The Burnham Institute, Sanford-Burnham Medical Research Institute, Burnham Institute for Medical Research. Active years: 1996-2015.

USPTO Granted Patents = 85 (Patent Applications = 13)

% Patents Active = 43.5

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 14

Forward Citations = 696(Granted Patents)

Forward Citations (Not Self Cited) = 660(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Philadelphia, PA (US) (1998)
Ranch Santa Fe, CA (US) (2010)
Carlsbad, CA (US) (1996 - 2011)
San Diego, CA (US) (2005 - 2011)
Rancho Santa Fe, CA (US) (1998 - 2012)
Rancho Sante Fe, CA (US) (2008 - 2013)
La Jolla, CA (US) (2009 - 2015)

Company Filing History:

32 out of 94

The Burnham Institute

patents

17 out of 99

Sanford-Burnham Medical Research Institute

patents

15 out of 55

Burnham Institute for Medical Research

patents

4. 13 out of 151

La Jolla Cancer Research Foundation

patents

5. 7 out of 2,645

University of Pennsylvania

patents

6. 2 out of 45

Torrey Pines Institute for Molecular Studies

patents

7. 1 out of 1

Burham Institute for Medical Research

patent

8. 1 out of 942

The University of New Mexico

patents

9. 1 out of 15,977

University of California

patents

where one patent can have more than one assignee

Years Active: 1996-2015

Loading Chart...

Areas of Expertise:

Apoptosis

Bcl Proteins

Cancer Cells

Inhibitors

Nucleic Acids

Prognosis

Caspase Activity

Cell Death

TRAF Proteins

Screening Assays

Microbial Proteases

Small Organic Molecules

85 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9115061 - Naphthalene-based inhibitors of anti-apoptotic proteins (2015-08-25),

2. 8367644 - Methods and compounds useful to induce apoptosis in cancer cells (2013-02-05),

3. 8273705 - Conversion of apoptotic proteins (2012-09-25),

4. 8119410 - Apoptosis modulator Bcl-B and methods for making and using same (2012-02-21),

5. 8119404 - Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them (2012-02-21),

6. 8071327 - Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity (2011-12-06),

7. 8071315 - Detecting Bcl-B expression in cancer and uses thereof (2011-12-06),

8. 8034901 - Bcl-G polypeptides, encoding nucleic acids and methods of use (2011-10-11),

9. 8008354 - Death receptor sensitizing compounds and methods of use therefor (2011-08-30),

10. 7994282 - Card proteins involved in cell death regulation (2011-08-09),

11. 7982023 - Bag proteins and nucleic acid molecules encoding them (2011-07-19),

12. 7982002 - Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto (2011-07-19),

13. 7951544 - Method for determining the prognosis of cancer patients by measuring levels of bag expression (2011-05-31),

14. 7927832 - Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto (2011-04-19),

15. 7927816 - Methods for identifying modulators of apoptosis (2011-04-19),

Title: The Innovative Journey of John C Reed

Introduction: John C Reed, a distinguished inventor hailing from Rancho Santa Fe, CA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: John C Reed's latest patents include a revolutionary software application for enhancing cybersecurity measures in financial institutions and a cutting-edge medical device designed to improve patient outcomes in critical care settings.

Career Highlights: With over two decades of experience in the tech industry, John C Reed has a proven track record of developing innovative solutions that address complex challenges. His work has been recognized with numerous awards and accolades, solidifying his reputation as a visionary inventor.

Collaborations: Throughout his career, John C Reed has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines and industries has led to the successful commercialization of several groundbreaking technologies.

Conclusion: John C Reed's passion for innovation and his relentless pursuit of excellence continue to drive his success in the world of inventions. His dedication to pushing the boundaries of what is possible serves as an inspiration to aspiring inventors and tech enthusiasts worldwide.